State Treasurer Dale Folwell is teaming up with Senator Bernie Sanders to scrutinize the costs of widely-used weight-loss drugs in North Carolina. Folwell has taken a strong stance against high drug prices, particularly in the case of drugs like Saxenda and Contrave, which have become popular among individuals seeking to lose weight.
Folwell, who oversees the state health plan for government employees, has been an outspoken critic of pharmaceutical companies and their pricing practices. He has raised concerns about the high costs of these weight-loss drugs, which can reach up to $1,300 per month, making them unaffordable for many individuals.
Senator Bernie Sanders has also been a vocal advocate for lowering drug prices and increasing access to affordable medications. He has praised Folwell for taking action on this issue and has called for greater transparency and accountability in the pharmaceutical industry.
The collaboration between Folwell and Sanders highlights a growing trend of government officials working together to address rising healthcare costs and make medications more affordable for consumers. By shining a spotlight on the costs of blockbuster weight-loss drugs, they hope to pressure pharmaceutical companies to reduce prices and make these treatments more accessible to those who need them.
As the debate over healthcare costs continues to escalate, the efforts of Folwell and Sanders to address the pricing of weight-loss drugs serve as a reminder of the importance of holding pharmaceutical companies accountable for their pricing strategies. With support from lawmakers and public officials, there is hope that meaningful change can be made to ensure that essential medications are affordable and accessible to all.
Source
Photo credit news.google.com